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ABSTRACT. The present study aims to explore the possible mechanisms underlying the
multidrug resistance characteristic of Cryptosporidium parvum by detecting the presence
of ATP-binding cassette (ABC) protein encoding genes, especially one that shows high
similarity to members belonging to the multidrug resistance protein (MDR) and multidrug
resistance associated protein (MRP) subfamilies. PCR using ABC-specific degenerate primers
successfully amplified two unique fragments, designated Cpnbd1 and Cpnbd2, from C. parvum
genomic DNA. Cpnbd1 exhibited high degree of homology (99-100%) with the nucleotide-
binding domains (NBDs) at the NH2-terminal halves of two previously reported ABC proteins
(CpABC and CpABC1) of human and bovine origin C. parvum isolates. It is likely that CpABC,
CpABC1 and Cpnbd1 were encoded by homologous genes of a type of ABC transporter protein
found in different C. parvum isolates. However, Cpnbd2 showed moderate levels of similarities
(28-49%) to the NBDs of four ABC proteins characterised in C. parvum to date. Therefore,
Cpnbd2 could be a novel member of an ABC superfamily of proteins in C. parvum.
Phylogenetic analyses on a list of ABC transporters known to associate with MDR phenotype
has significantly linked Cpnbd1 and Cpnbd2 to these transporters, thus suggesting that Cpnbd1
and Cpnbd2 proteins may contribute to the intrinsic multidrug resistance phenotype of C.
parvum.
INTRODUCTION
Cryptosporidium parvum is an intestinal
parasitic protozoa which causes self-
limited diarrhoea in immunocompetent
individuals and devastating and fulminant
diarrhoea in immunocompromised patients
(Griffiths, 1998). Despite extensive effort
in searching for chemotherapeutic agents
against cryptosporidiosis, it remains
elusive. The major impediment in the use
of a promising chemotherapeutic
compound is the intrinsic multidrug
resistance exhibited by C. parvum
towards an array of drugs that is generally
effective against similar organisms (Chen
et al., 2002). It is postulated that the
intrinsic multidrug resistance of C.
parvum is mediated by a general
transporting mechanism, possibly by the
ATP-binding cassette (ABC) superfamily of
transporters.
The ABC superfamily of transporters,
which consists of more than 1,000
members, is the largest and most
widespread protein family known to date.
The vast majority of its members are ATP
driven transporters, which is responsible
of translocating a wide variety of
compounds across biological membranes
(Higgins, 1992; Ambudkar et al., 1999).
Most ABC transporters share a similar
architecture: a fundamental structure
made up of four domains. Two of these
domains are the hydrophobic membrane-
spanning domains (MSDs), and two other
domains are the hydrophilic nucleotide-
binding domains (NBDs). NBDs are
evolutionally conserved domains, which
have considerable sequence homologies
across the entire family, and the
homologies range from 30% to 50%. Two
NBDs within a transporter show higher
similarity to each other than to the
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respective domains from other member of
transporter (Higgins, 1992; Ambudkar et
al., 1999).
In addition to their physiological
functions, ABC proteins have enormous
medical relevance. Members of the
superfamily, the multidrug resistance
protein (MDR) (Juliano & Ling, 1976) and
multidrug resistance associated protein
(MRP) (Cole & Deeley, 1993), are almost
always associated with the multidrug
resistance phenomenon exhibited by many
intrinsic or acquired drug resistance
cancer cell lines or human pathogens
(Davidson, 2002). Transfection studies and
investigation on the drug sensitive partial
revertant cell lines clearly elaborated the
correlation between MDR, MRP and
multidrug resistance phenotypes (Gao et
al., 1998).
The present study aimed to explore
and characterise the possible mechanisms
underlying the MDR characteristic of C.
parvum by detecting the presence of ABC
transporter protein encoding genes,
especially one that shows high similarity to
members belonging to the MDR and MRP
subfamilies of transporters.
MATERIALS AND METHODS
C. parvum genomic DNA extraction
C. parvum oocysts (IOWA isolate, bovine
genotype) used in this study were
purchased from Waterborne Inc, USA.
Genomic DNA was extracted from the
oocysts by using the QIAamp DNA blood
mini kit (QIAGEN, Germany).
Degenerate primers for PCR
amplification of ABC transporter
encoding genes
PCR approach using degenerate primers,
was used to identify ABC transporter
encoding genes in C. parvum. The sense
and antisense primers corresponding to
peptide GCGKST(L/I)(I/L) and (G/A)(V/
S)KLSGGQ were selected based on the
analysis of the highly conserved NBDs of
several ABC transporter proteins
(Dallagiovanna et al., 1994). The
degeneracy of the primers was adjusted to
account for the codon bias found for C.
parvum genes.
PCR amplification of ABC transporter
encoding genes
The amplification of C. parvum ABC
transporter protein genes involved two
rounds of PCR, namely the primary and
secondary amplifications. In primary
amplification, degenerate primers were
incubated with C. parvum genomic DNA,
according to standard protocol, in a
volume of 20µl. The optimum PCR
annealing temperature was 55ºC. The
secondary PCR amplification condition
was identical to the first round, except that
1 µl of 50X diluted primary PCR products
was used as DNA template.
PCR product purification and cloning
The QIAquick gel extraction kit (QIAGEN,
Germany) was used to extract DNA bands
from agarose gels. Purified PCR products
were cloned into pGEM®-T vector
(Promega, USA), and transformed into
Escherichia coli JM109 strain (Promega,
USA).
Sequencing analyses
The resultant positive recombinant
clones were sequenced in both directions
on an ABI PRISM® 377 DNA sequencer
(BST Techlab, Singapore). Sequencing
was primed using T7 forward and SP6
reverse promoter primers encoded on the
pGEM®-T.
Nucleotide and amino acid sequences
were compared with the sequences
deposited in National Center for
Biotechnology Information (NCBI,
National Institutes of Health, USA)
databases via the BLAST server. Multiple
alignments of DNA and protein sequences
were performed using the ClustalW
programme. Protein similarities were
calculated using the GeneDoc sequence
editor. Conservative amino acids are
grouped as: (D,E,N,Q,H) (S,A,T) (K,R) (F,Y)
(L,I,V,M). The aligned protein sequences
were analysed by distance based
neighbour-joining method, using the Njplot
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programme. Bootstrap replicates of 1000
were set to assess the reliability of the
tree. An unrooted tree was also constructed
by using the Njplot.
RESULTS AND DISCUSSION
PCR using ABC-specific degenerate
primers successfully amplified two unique
fragments from C. parvum genomic DNA.
Sequencing of the fragments revealed two
partial open reading frames (ORFs). ORF1
was 279 base pairs in length, which
encoded a peptide of 93 amino acids. ORF2
was 303 base pairs in length, and encoded
a 101-amino acid peptide. Comparisons of
ORF1 and ORF2 to the protein sequences
in the NCBI databases revealed that both
fragments shared high similarities with
NBDs of a variety of ABC transporters.
Thus, ORF1 and ORF2 were respectively
designated Cpnbd1 and Cpnbd2. For
protein sequences, they were designated
as Cpnbd1 and Cpnbd2 [Figures 1(a) and
(b)].
Comparisons of Cpnbd1 and Cpnbd2
with the NBDs of C. parvum ABC
proteins
At the amino acids level, Cpnbd1 was 100%
identical to the NH2-terminal half (_N) of
CpABC1, an ABC protein characterised in
C. parvum KSU-1 isolate (bovine
genotype) (Zapata et al., 2002). At the
nucleotide level, both gene fragments
showed 99% identity. The difference was
due to a single nucleotide substitution at
the third position of codon-33, which was
a silent substitution, as both CAG99 in
Cpnbd1 and CAA99 in CpABC1_N codes for
the amino acid glutamine.
Cpnbd1 also showed high similarity to
the NBD at the NH2-terminal of CpABC,
the gene encoding the ABC protein of C.
parvum SFGH1, an isolate of human
genotype (Perkin et al., 1999). Both
proteins were 97% and 98% identical at
amino acid and nucleotide levels,
respectively, and the differences were
attributed to four nucleotide substitutions.
Two of the nucleotide substitutions
resulted in silent changes: CAG99 at codon-
33 of Cpnbd1 and CAA99 of CpABC_N,
which codes for glutamine, and GAT174 at
codon-58 of Cpnbd1 and GAC174 of
CpABC_N, which codes for aspartic acid.
Two other nucleotide substitutions, which
occurred at the first position of the
corresponding codons, resulted in amino
acid changes. These were the 64ATT at
codon-22 of Cpnbd1, which codes for
isoleucine, and the corresponding codon
64GGT at CpABC_N, which codes for
valine. Whereas at codon-42, 124GTT of
Cpnbd1 coding for valine while 124ATT of
CpABC_N coding for isoleucine. The high
degree of similarities between Cpnbd1,
CpABC and CpABC1 implied that they
could be encoded by homologous genes of
a type of ABC transporter protein found in
different C. parvum isolates.
As for Cpnbd2, it showed moderate
similarities (28 – 49 %) to the NBDs at both
NH2- and COOH-terminal halves of ABC
proteins characterised in C. parvum to
date (Table 1). Therefore, Cpnbd2 could be
a novel member of an ABC superfamily of
proteins in C. parvum.
Comparisons of Cpnbd1 and Cpnbd2
with the NBDs of ABC proteins of
some drug resistance cells
Multiple alignment (Figures 2 and 3) and
phylogenetic (Figure 4) analyses on a
list of ABC transporters known to
associate with MDR phenotype (EhPGP
5: Entamoeba histolytica P-gp-like
transporters 5; EhPGP 6: E. histolytica
P-gp-like transporters 6; HuABCB1:
Homo sapien ATP-binding cassette B1;
HuABCC1: H. sapien ATP-binding cassette
C1; HuABCC2: H. sapien ATP-binding
cassette C2; LaMDR1: Leishmania
amazonensis multidrug resistance protein
1; Ldmdr1: L. donovani Multidrug
resistance protein 1; LeMDR1: L. enrietti
multidrug resistance protein-like 1;
TbMRPA: Trypanosoma brucei multidrug
resistance protein A; and TbMRPE: T.
brucei multidrug resistance protein E) has
strongly linked Cpnbd1 to HuABCC1 and
HuABCC2.
118
Table 1. Quantitative analysis of amino
acid similarities between Cpnbd1, Cpnbd2
and the NBD at the NH2-terminal (_N)
half and COOH-terminal (_C) half of the
ABC proteins of several drug resistant
parasitic protozoan and H. sapiens
ABC protein
              Similarity (%)
Cpnbd1 Cpnbd2
CpABC_N 100 30
CpABC_C 46 43
CpABC1_N 100 30
CpABC1_C 46 46
CpABC2_N 58 28
CpABC2_C 40 49
CpABC3_N 37 36
CpABC3_C 41 35
EhPGP5_N 43 36
EhPGP5_C 37 36
EhPGP6_N 30 37
EhPGP6_C 40 32
HuABCA5_N Nil 65
HuABCB1_N 35 39
HuABCB1_C 36 33
HuABCC1_N 68 32
HuABCC1_C 36 41
HuABCC2_N 68 32
HuABCC2_C 39 34
LaMDR1_N 37 36
LaMDR1_C 41 30
Ldmdr1_N 37 36
Ldmdr1_C 42 30
LeMDR1_N 36 35
LeMDR1_C 40 31
TbMRPA_N 59 39
TbMRPA_C 36 37
TbMRPE_N 60 38
TbMRPE_C 39 39
TcABCA1_N Nil 54
HuABCC1 is a human MRP transporter
identified in the H69AR doxorubicin-
selected human lung carcinoma cell line
(Mirski et al., 1987). In normal tissue,
HuABCC1 is found ubiquitously expressed
at low levels. Certain normal tissues,
however, do highly express HuABCC1 at
cellular levels. In human cancer cells,
HuABCC1 has been found overexpressed
in various cancer types. In certain
cancer types, HuABCC1 expression is
an important predictor of treatment
outcome. The expression of HuABCC1 is
usually highest in tumours that derived
from tissues that normally express the
transporter protein, and tumours arising
from these tissues are known to be
intrinsically resistant against chemo-
therapeutic treatment (Cole et al., 1994;
Hipfner et al., 1999).
HuABCC2 is the second member
identified in the MRP subfamily of
transporter in human. Taniguchi et al.
(1996) successfully isolated the HuABCC2
encoding gene from a cisplatin-resistant
human cancer cell line. The research group
also reported good correlation between
cisplatin resistance and the up-regulation
expression of HuABCC2. HuABCC2 has
been detected in the liver, kidneys,
intestine, placenta and the brain at normal
level. HuABCC2 is believed to play an
important role in eliminating endogenous
toxic compounds and xenobiotics from the
body. In hepatocytes, the expression of
HuABCC2 is markedly increased by
various chemical carcinogen and
chemopreventive agents (Payen et al.,
2002). Meanwhile, intestinal HuABCC2
may play a role in reducing the level of 2-
amino-1-methyl-6-phenylimidazo [4,5-6]
pyridine; the most abundant food derived
carcinogen, which is formed during
cooking, frying and grilling of meat
(Dietrich et al., 2001).
The relationship of Cpnbd2 with the
same group of transporters was less
distinct. It was clustered in a clade which
consisted of the NBDs of various ABC
transporter proteins (Figure 4). The
similarities of Cpnbd2 to these NBDs were
generally moderate (Table 1). Interestingly,
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Figure 1. Nucleotide and deduced amino acid sequences of (a) Cpnbd1/Cpnbd1, and (b) Cpnbd2/
Cpnbd2. Nucleotide sequences are indicated by small letters, whereas the deduced amino acid
sequences are indicated by capital letters and are represented by single-letter codes.
Figure 2. Comparison of the amino acid sequences of Cpnbd1 and the NBDs of ABC proteins from
C. parvum and H. sapiens. Similar amino acids shared by all, 70% and 50% of the aligned
sequences, are boxed by black, dark grey and light grey, respectively.
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Figure 3. Comparison of the amino acid sequences of Cpnbd2 and the NBDs of ABC proteins from
C. parvum, H. sapiens and T. cruzi. Similar amino acids shared by all and two of the aligned
sequences, are boxed by black and dark grey, respectively.
Figure 4. Phylogenetic relationship of NBDs among various ABC superfamily of
proteins. Cpnbd1 is closely related to CpABC_N and CpABC1_N, the ABC proteins of
C. parvum KSU-1 isolate and C. parvum SFGH1 isolate, respectively. Cpnbd2, however,
is moderately related to the T. cruzi (TcABC1_C) and human (HuABCA5_N) ABC
proteins.
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Cpnbd2 did show significant high similarity
to the NBDs at the NH2-terminal halves of
two ABC proteins [the H. sapien ATP-
binding cassette A5 (HuABCA5) and T.
cruzi ABCA1 transporter (TcABCA1)]. It
was 65% similar to HuABCA5_N and 59%
similar to TcABCA1_N. However, neither
the substrate nor the function of HuABCA5
and TcABCA1 is known (Dean et al., 2001).
The possible function of Cpnbd2,
therefore, cannot be inferred from the
phylogenetic analysis.
The study of ABC protein family in C.
parvum is considered at its infancy as no
functional study has thus far been
conducted on any of the characterised
ABC proteins of the parasite. In
intracellular stages, CpABC1 is located at
the host-parasite boundary of mature
meronts. The location of CpABC1 suggests
that it could be a component of one or
more of the membranes (the meront
plasma membrane, the parasitophorous
vacuole membrane, or the feeder
organelle) at the host-parasite boundary
(Zapata et al., 2002). Similar observation
was reported by Perkin et al. (1999) on
CpABC. The peculiar location of CpABC
and CpABC1, suggests that these proteins
may play a role in metabolic interaction
between the parasite and the infected host.
The localisation of both proteins also
correlates well and supports a role as drug
efflux pumps that transport endogenous
and xenobiotics away from the parasite.
Since some genes of the P-gp and MRP
subfamilies of transporters have been
associated with MDR phenomenon in
cancer patients and certain drug resistance
pathogens, the presence of such
homologous protein in C. parvum may
also attribute to the intrinsic MDR
phenotype of the parasite.
Acknowledgements We would like to
acknowledge the Ministry of Science,
Technology and Innovation for granting the
National Science Fellowship to Ms Li-Li
Chan. This project was supported by the
University of Malaya Vote F Research
Grants F0132/2001A and F0194/2004A.
REFERENCES
Ambudkar, S.V., Dey, S., Hrycyna, C.A.,
Ramachandra, M., Pastan, I. &
Gottesman, M.M. (1999). Biochemical,
cellular, and pharmacological aspects
of the multidrug transporter. Annual
Review of Pharmacology and
Toxicology 39: 361–398.
Chen, X.M., Keithly, J.S., Paya, C.V. & La
Russo, N.F. (2002). Cryptosporidiosis.
New England Journal of Medicine
346: 1723–1731.
Cole, S.P., & Deeley, R.G. (1993). Multidrug
resistance-associated protein:
sequence correction. Science 260: 879.
Cole, S.P., Sparks, K.E., Fraser, K., Loe,
D.W., Grant, C.E., Wilson, G.M. &
Deeley, R.G. (1994). Pharmacological
characterization of multidrug resistant
MRP-transfected human tumor cells.
Cancer Research 54: 5902–5910.
Dallagiovanna, B., Castanys, S. & Gamarro,
F. (1994). Trypanosoma cruzi:
sequence of the ATP-binding site of a
P-glycoprotein gene. Experimental
Parasitology 79: 63–67.
Davidson, A.L. (2002). Mechanism of
coupling of transport to hydrolysis in
bacterial ATP-binding cassette
transporters. Journal of Bacteriology
184: 1225–1233.
Dean, M., Hamon, Y. & Chimini, G. (2001).
The human ATP-binding cassette
(ABC) transporter superfamily.
Journal of Lipid Research 42:1007–
1017.
Dietrich, C.G., de Waart, D.R., Ottenhoff,
R., Bootsma, A.H., van Gennip, A.H. &
Elferink, R.P. (2001). Mrp2-deficiency
in the rat impairs biliary and intestinal
excretion and influences metabolism
and disposition of the food-derived
carcinogen 2-amino-1-methyl-6-
phenylimidazo. Carcinogenesis 22:
805–811.
Gao, M., Yamazaki, M., Loe, D.W.,
Westlake, C.J., Grant, C.E., Cole, S.P. &
Deeley, R.G. (1998). Multidrug
resistance protein. Identification of
regions required for active transport of
122
leukotriene C4. Journal of Biological
Chemistry 273: 10733–10740.
Griffiths, J.K. (1998). Human
cryptosporidiosis: epidemiology,
transmission, clinical disease,
treatment, and diagnosis. Advance
Parasitology 40: 37–85.
Higgins, C.F. (1992). ABC transporters:
from microorganisms to man. Annual
Review of Cell Biology 8: 67–113.
Hipfner, D.R., Deeley, R.G. & Cole, S.P.
(1999). Structural, mechanistic and
clinical aspects of MRP1. Biochimica
et Biophysica Acta 1461: 359–376.
Juliano, R.L. & Ling, V. (1976). A surface
glycoprotein modulating drug
permeability in Chinese hamster
ovary cell mutants. Biochimica et
Biophysica Acta 455: 152–162.
Mirski, S.E., Gerlach, J.H. & Cole, S.P.
(1987). Multidrug resistance in a
human small cell lung cancer cell
line selected in adriamycin. Cancer
Research 47: 2594–2598.
Payen, L., Sparfel, L., Courtois, A., Vernhet,
L., Guillouzo, A. & Fardel, O. (2002).
The drug efflux pump MRP2:
regulation of expression in
physiopathological situations and
by endogenous and exogenous
compounds. Cell Biology and
Toxicology 18: 221–233.
Perkins, M.E., Riojas, Y. A., Wu, T.W. &
Le Blancq, S.M. (1999). CpABC, a
Cryptosporidium parvum  ATP-
binding cassette protein at the host-
parasite boundary in intracellular
stages. Proceedings of the National
Academy of Sciences USA 96: 5734–
5739.
Taniguchi, K., Wada, M., Kohno, K.,
Nakamura, T., Kawabe, T., Kawakami,
M., Kagotani, K., Okumura, K.,
Akiyama, S. & Kuwano, M. (1996). A
human canalicular multispecific
organic anion transporter (cMOAT)
gene is overexpressed in cisplatin-
resistant human cancer cell lines with
decreased drug accumulation. Cancer
Research 56: 4124–4129.
Zapata, F., Perkins, M.E., Riojas, Y.A., Wu,
T.W. & Le Blancq, S.M. (2002). The
Cryptosporidium parvum  ABC
protein family. Molecular and
Biochemical Parasitology 120: 157–
161.
